Novo Nordisk has been swept up in uncertainty around U.S. tariffs and Washington's push to get firms to lower drug prices and move manufacturing stateside.

Novo Nordisk has been swept up in uncertainty around U.S. tariffs and Washington's push to get firms to lower drug prices and move manufacturing stateside.

Weight-loss drug Wegovy may lower the risk of heart attack, stroke or death more than similar medications, research by drug manufacturer Novo Nordisk suggests.